NIMENRIX meningococcal (Groups A, C, W-135, Y) polysaccharide tetanus toxoid conjugate vaccine injection vial and diluent syringe
Back
Updated Date:
11 Aug 2026
Product Detail:
NIMENRIX meningococcal (Groups A, C, W-135, Y) polysaccharide tetanus toxoid conjugate vaccine injection vial and diluent syringe
Shortage Status:
Anticipated
AUST R:
199742
Availability:
Available
Active Ingredient:
Meningococcal polysaccharide group W135~Meningococcal polysaccharide group C~Meningococcal polysaccharide Group Y~Meningococcal polysaccharide group A~Tetanus toxoid
Reason:
Unexpected increase in consumer demand
Dosage Form:
Injection,powderfor
Supply Impact Dates
From 01 Nov 2026
To 30 Nov 2026
Management Action:
Alternative brands are available. The sponsor has advised that stock will continue to be available for supply under the National Immunisation Program.